These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 35112366)

  • 1. Genomic, immunological, and clinical analysis of COVID-19 vaccine breakthrough infections in Beijing, China.
    Tian D; Song Y; Zhang M; Pan Y; Ge Z; Zhang Y; Ren X; Wen J; Xu Y; Guo H; Yang P; Chen Z; Xu W
    J Med Virol; 2022 May; 94(5):2237-2249. PubMed ID: 35112366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
    Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
    JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York.
    Duerr R; Dimartino D; Marier C; Zappile P; Levine S; Francois F; Iturrate E; Wang G; Dittmann M; Lighter J; Elbel B; Troxel AB; Goldfeld KS; Heguy A
    EBioMedicine; 2022 Aug; 82():104141. PubMed ID: 35906172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
    Servellita V; Morris MK; Sotomayor-Gonzalez A; Gliwa AS; Torres E; Brazer N; Zhou A; Hernandez KT; Sankaran M; Wang B; Wong D; Wang C; Zhang Y; Reyes KR; Glasner D; Deng X; Streithorst J; Miller S; Frias E; Rodgers M; Cloherty G; Hackett J; Hanson C; Wadford D; Philip S; Topper S; Sachdev D; Chiu CY
    Nat Microbiol; 2022 Feb; 7(2):277-288. PubMed ID: 35013591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Genomic Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Infections in mRNA Vaccinated Health Care Personnel in New York City.
    Robilotti EV; Whiting K; Lucca A; Poon C; Guest R; McMillen T; Jani K; Solovyov A; Kelson S; Browne K; Freeswick S; Hohl TM; Korenstein D; Ruchnewitz D; Lässig M; Łuksza M; Greenbaum B; Seshan VE; Esther Babady N; Kamboj M
    Clin Infect Dis; 2022 Aug; 75(1):e774-e782. PubMed ID: 34644393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Genomic Variation Associated With Breakthrough Infection in Northern California: A Retrospective Cohort Study.
    Skarbinski J; Nugent JR; Wood MS; Liu L; Bullick T; Schapiro JM; Arunleung P; Morales C; Amsden LB; Hsiao CA; Wadford DA; Chai SJ; Reingold A; Wyman SK
    J Infect Dis; 2023 Oct; 228(7):878-888. PubMed ID: 37195913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic monitoring unveils a high prevalence of severe acute respiratory syndrome coronavirus 2 Omicron variant in vaccine breakthrough cases in Bahia, Brazil.
    Campos GS; Giovanetti M; Moraes L; Hora HSD; Bandeira ACA; Alcantara KVOM; Sardi SI
    Rev Assoc Med Bras (1992); 2023; 69(2):257-261. PubMed ID: 36888766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai.
    Shetty A; Chatterjee G; Rajpal S; Srivastava T; Gardi N; Mirgh S; Gokarn A; Punatar S; Shetty N; Joshi A; Nair S; Murthy V; Khattry N; Tembhare P; Dikshit R; Chaturvedi P; More A; Kamtalwar S; Chavan P; Bhat V; Patil A; Dhumal S; Bhat P; Subramanian P; Gujral S; Badwe R; Patkar N; Gupta S
    Int J Clin Pract; 2022; 2022():2449068. PubMed ID: 35685574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico.
    Galán-Huerta KA; Flores-Treviño S; Salas-Treviño D; Bocanegra-Ibarias P; Rivas-Estilla AM; Pérez-Alba E; Lozano-Sepúlveda SA; Arellanos-Soto D; Camacho-Ortiz A
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study.
    Xu C; He Z; Lei W; Chen L; Shen D; Wang X; Xu D; Xu Y; Huang J
    BMC Infect Dis; 2022 Nov; 22(1):831. PubMed ID: 36352356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals.
    Caserta LC; Martins M; Cronk B; Anderson R; Eldridge H; Gallow D; Kruppa F; Plocharczyk E; Diel DG
    Microbiol Spectr; 2022 Oct; 10(5):e0056322. PubMed ID: 36165775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis.
    Manley HJ; Li NC; Aweh GN; Hsu CM; Weiner DE; Miskulin D; Harford AM; Johnson D; Lacson E
    Am J Kidney Dis; 2023 Apr; 81(4):406-415. PubMed ID: 36462570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Acute Respiratory Syndrome Coronavirus 2 Delta Vaccine Breakthrough Transmissibility in Alachua County, Florida.
    Rife Magalis B; Rich S; Tagliamonte MS; Mavian C; Cash MN; Riva A; Marini S; Amador DM; Zhang Y; Shapiro J; Horine A; Starostik P; Pieretti M; Vega S; Paula Lacombe A; Salinas J; Stevenson M; Myers P; Glenn Morris J; Lauzardo M; Prosperi M; Salemi M
    Clin Infect Dis; 2022 Oct; 75(9):1618-1627. PubMed ID: 35271704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of SARS-CoV-2 genomic surveillance data during the Delta and Omicron waves at a Saudi tertiary referral hospital.
    Obeid D; Al-Qahtani A; Almaghrabi R; Alghamdi S; Alsanea M; Alahideb B; Almutairi S; Alsuwairi F; Al-Abdulkareem M; Asiri M; Alshukairi A; Alkahtany J; Altamimi S; Mutabagani M; Althawadi S; Alanzi F; Alhamlan F
    J Infect Public Health; 2023 Feb; 16(2):171-181. PubMed ID: 36543031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants.
    Kislaya I; Rodrigues EF; Borges V; Gomes JP; Sousa C; Almeida JP; Peralta-Santos A; Nunes B;
    Emerg Infect Dis; 2022 Feb; 28(2):331-337. PubMed ID: 34876242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas.
    Christensen PA; Olsen RJ; Long SW; Subedi S; Davis JJ; Hodjat P; Walley DR; Kinskey JC; Ojeda Saavedra M; Pruitt L; Reppond K; Shyer MN; Cambric J; Gadd R; Thakur RM; Batajoo A; Mangham R; Pena S; Trinh T; Yerramilli P; Nguyen M; Olson R; Snehal R; Gollihar J; Musser JM
    Am J Pathol; 2022 Feb; 192(2):320-331. PubMed ID: 34774517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons With Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a High-Risk National Population.
    Butt AA; Yan P; Shaikh OS; Mayr FB; Omer SB
    Clin Infect Dis; 2022 Aug; 75(1):e849-e856. PubMed ID: 34893812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection.
    Goto T; Tani N; Ikematsu H; Gondo K; Oishi R; Minami J; Onozawa K; Kuwano H; Akashi K; Shimono N; Chong Y
    PLoS One; 2022; 17(7):e0272056. PubMed ID: 35877668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].
    Ayhancı T; Toptan H; Özer YE; Uzar S; Enül H; Adıay C; Sarac F; Dheir H; Köroğlu M; Hasöksüz M; Altındiş M
    Mikrobiyol Bul; 2022 Jul; 56(3):416-431. PubMed ID: 35960235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada.
    Fibke CD; Joffres Y; Tyson JR; Colijn C; Janjua NZ; Fjell C; Prystajecky N; Jassem A; Sbihi H
    Front Public Health; 2022; 10():915363. PubMed ID: 35859775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.